88 related articles for article (PubMed ID: 1950028)
1. [Ranitidine in the therapy and prevention of NSAR-induced (non-steroidal anti-rheumatic agents) gastroduodenal lesions in patients with rheumatism].
Simon B; Bergdolt H; Dammann H; Müller P
Z Gastroenterol; 1991 May; 29(5):217-21. PubMed ID: 1950028
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of non-steroidal anti-inflammatory drug-induced damage to gastric mucosa using ranitidine. Comparison of the effectiveness of 2 dosages].
Müller P; Dammann HG; Marinis E; Weise D; Simon B
Fortschr Med; 1989 Oct; 107(31):667-70. PubMed ID: 2687142
[TBL] [Abstract][Full Text] [Related]
3. [Nizatidine in therapy and prevention of non-steroidal anti-rheumatic drug-induced ulcers in rheumatic patients].
Simon B; Leucht U; Amon I; Brandau J; Müller P
Z Gastroenterol; 1993 Jun; 31(6):395-400. PubMed ID: 8212757
[TBL] [Abstract][Full Text] [Related]
4. [Ranitidine in the treatment of non-steroidal anti-inflammatory agent-induced damage of the stomach and duodenal mucosa. Results of a randomized, placebo-controlled double-blind study in patients with rheumatic diseases].
Simon B; Beckers KH; Biewer W; Bouzo MH; Dammann HG; Gebest HJ; Müller P; Schütz E
Z Gastroenterol; 1988 Jun; 26(6):310-3. PubMed ID: 3061183
[TBL] [Abstract][Full Text] [Related]
5. Misoprostol prevents NSAID-induced gastroduodenal lesions in patients with osteoarthritis and rheumatoid arthritis.
Saggioro A; Alvisi V; Blasi A; Dobrilla G; Fioravanti A; Marcolongo R
Ital J Gastroenterol; 1991; 23(3):119-23. PubMed ID: 1742504
[TBL] [Abstract][Full Text] [Related]
6. [Ulcer healing with ranitidine and antacids despite continued therapy with non-steroidal anti-rheumatic drugs].
Stock KP; Bach GL
Z Rheumatol; 1988; 47(3):177-81. PubMed ID: 3213266
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
8. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
[TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
Dajani EZ; Agrawal NM
J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
[TBL] [Abstract][Full Text] [Related]
10. [NSAID-induced ulcers--therapy and prevention].
Rösch W
Z Rheumatol; 1995; 54(1):2-8; discussion 9-11. PubMed ID: 7725807
[TBL] [Abstract][Full Text] [Related]
11. [Antisecretory drugs and prophylaxis of secondary gastrointestinal effects associated with the consumption of non steroid anti-inflammatory drugs].
Lanas A; Arroyo MT
Med Clin (Barc); 2000; 114 Suppl 2():57-62. PubMed ID: 10916808
[TBL] [Abstract][Full Text] [Related]
12. [Gastroduodenal lesions in rheumatoid arthritis. Evaluation and treatment].
Martínez RO; Casas H; Mazure PA; Leczycki H; Cosen JN; Canievsky L; Abib A
Acta Gastroenterol Latinoam; 1988; 18(2):87-96. PubMed ID: 3075109
[TBL] [Abstract][Full Text] [Related]
13. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
[TBL] [Abstract][Full Text] [Related]
14. [De-nol in NSAID-induced gastroduodenal lesions].
Cataldo MG; D'Aiuto A; Bongiorno A
Minerva Dietol Gastroenterol; 1990; 36(1):27-30. PubMed ID: 2186304
[TBL] [Abstract][Full Text] [Related]
15. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
Bianchi Porro G; Lazzaroni M; Petrillo M; Manzionna G; Montrone F; Caruso I
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):43-7. PubMed ID: 9615264
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
Scarpignato C; Pelosini I
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal lesions during treatment with non-steroidal anti-inflammatory drugs (NSAIDs).
Festen HP
Neth J Med; 1989 Dec; 35(5-6):327-33. PubMed ID: 2699655
[TBL] [Abstract][Full Text] [Related]
18. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy.
McCarthy DM
J Clin Gastroenterol; 1990; 12 Suppl 2():S13-20. PubMed ID: 1978842
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of antihelicobacter therapy in NSAID-induced gastropathies].
Karateev AE; Murav'ev IuV; Radenska-Lopovok SG; Nasonova VA
Klin Med (Mosk); 2003; 81(8):37-41. PubMed ID: 14520944
[TBL] [Abstract][Full Text] [Related]
20. Prevention of NSAID-induced GI mucosal injury.
Gerritz S; Newton WP
J Fam Pract; 1997 Feb; 44(2):130-1. PubMed ID: 9040509
[No Abstract] [Full Text] [Related]
[Next] [New Search]
